Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie Findlow

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Nasopharyngeal colonization by Neisseria lactamica and induction of protective immunity against Neisseria meningitidisCariad M Evans, Catherine B Pratt, Mary Matheson, et al.
Emerging Infectious Diseases|January 27, 2016
Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, EnglandShamez N Ladhani, Marzia Monica Giuliani, Alessia Biolchi, et al.
The Pediatric Infectious Disease Journal|February 16, 2012
Immunogenicity of a single dose of meningococcal group C conjugate vaccine given at 3 months of age to healthy infants in the United kingdomHelen Findlow, Ray Borrow, Nick Andrews, et al.
Clinical and Vaccine Immunology : CVI|December 3, 2010
Molecular targets in meningococci: efficient routine characterization and optimal outbreak investigation in conjunction with routine surveillance of the meningococcal group B vaccine candidate, fHBPJay Lucidarme, Lynne S Newbold, Jamie Findlow, et al.
Journal of Occupational Medicine and Toxicology (London, England)|July 30, 2014
Evaluation of the safety and immunogenicity in United Kingdom laboratory workers of a combined Haemophilus influenzae type b and meningococcal capsular group C conjugate vaccineJamie Findlow, Helen Findlow, Sarah Frankland, et al.
BMC Public Health|December 10, 2020
Systematic literature review of the impact and effectiveness of monovalent meningococcal C conjugated vaccines when used in routine immunization programsMyint Tin Tin Htar, Sally Jackson, Paul Balmer, et al.
Vaccine|December 4, 2016
A phase III observer-blind randomized, controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B meningococcal vaccineRobert C Read, Peter Dull, Xilian Bai, et al.
Vaccine|August 20, 2013
Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverageGiacomo Frosi, Alessia Biolchi, Morena Lo Sapio, et al.
Emerging Infectious Diseases|January 21, 2012
Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009Shamez N Ladhani, Jay Lucidarme, Lynne S Newbold, et al.
Plos One|October 8, 2013
The distribution and 'in vivo' phase variation status of haemoglobin receptors in invasive meningococcal serogroup B disease: genotypic and phenotypic analysisJay Lucidarme, Jamie Findlow, Hannah Chan, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Nasopharyngeal colonization by Neisseria lactamica and induction of protective immunity against Neisseria meningitidisCariad M Evans, Catherine B Pratt, Mary Matheson, et al.
Emerging Infectious Diseases|January 27, 2016
Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, EnglandShamez N Ladhani, Marzia Monica Giuliani, Alessia Biolchi, et al.
The Pediatric Infectious Disease Journal|February 16, 2012
Immunogenicity of a single dose of meningococcal group C conjugate vaccine given at 3 months of age to healthy infants in the United kingdomHelen Findlow, Ray Borrow, Nick Andrews, et al.
Clinical and Vaccine Immunology : CVI|December 3, 2010
Molecular targets in meningococci: efficient routine characterization and optimal outbreak investigation in conjunction with routine surveillance of the meningococcal group B vaccine candidate, fHBPJay Lucidarme, Lynne S Newbold, Jamie Findlow, et al.
Journal of Occupational Medicine and Toxicology (London, England)|July 30, 2014
Evaluation of the safety and immunogenicity in United Kingdom laboratory workers of a combined Haemophilus influenzae type b and meningococcal capsular group C conjugate vaccineJamie Findlow, Helen Findlow, Sarah Frankland, et al.
BMC Public Health|December 10, 2020
Systematic literature review of the impact and effectiveness of monovalent meningococcal C conjugated vaccines when used in routine immunization programsMyint Tin Tin Htar, Sally Jackson, Paul Balmer, et al.
Vaccine|December 4, 2016
A phase III observer-blind randomized, controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B meningococcal vaccineRobert C Read, Peter Dull, Xilian Bai, et al.
Vaccine|August 20, 2013
Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverageGiacomo Frosi, Alessia Biolchi, Morena Lo Sapio, et al.
Emerging Infectious Diseases|January 21, 2012
Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009Shamez N Ladhani, Jay Lucidarme, Lynne S Newbold, et al.
Plos One|October 8, 2013
The distribution and 'in vivo' phase variation status of haemoglobin receptors in invasive meningococcal serogroup B disease: genotypic and phenotypic analysisJay Lucidarme, Jamie Findlow, Hannah Chan, et al.
Pageof 10